Therefore, one of our research plans in the future is to study the difference in clinical impact between breast cancer in which PBK/TOPK is mainly expressed in the nucleus of cancer cells and that in which it is mainly expressed in the cytoplasm of the cancer cells. This evidence concerns the gene PBK and breast cancer.